PropertyValue
?:abstract
  • The currently emerging pathogen SARS-CoV-2 has produced the global pandemic crisis by causing COVID-19. The unique and novel genetic makeup of SARS-CoV-2 has been created puzzle in biological research, due to which the potential drug/vaccine candidates have not yet been discovered by the scientific community. Meanwhile, the advantages of bioinformatics in viral research had created a milestone since last few decades. The exploitation of bioinformatics tools and techniques has successfully interpreted this viral genomics architecture. Some major in silico studies involving next-generation sequencing, genome-wide association studies, computer-aided drug design etc. have been effectively applied in COVID-19 research methodologies and discovered novel information on SARS-CoV-2 in several ways. Nowadays the implementation of in silico studies in COVID-19 research has not only sequenced the SARS-CoV-2 genome but also properly analyzed the sequencing errors, evolutionary relationship, genetic variations, putative drug candidates against SARS-CoV-2 viral genes etc. within a very short time period. These would be very needful towards further research on COVID-19 pandemic and essential for vaccine development against SARS-CoV-2 which will save public health.
is ?:annotates of
?:creator
?:doi
  • 10.1016/j.mgene.2020.100844
?:doi
?:journal
  • Meta_Gene
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/b71d86ca3cfffd311556dcd30222c712029be327.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7744275.xml.json
?:pmcid
?:pmid
?:pmid
  • 33349792.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Elsevier; Medline; PMC
?:title
  • Essential interpretations of bioinformatics in COVID-19 pandemic
?:type
?:year
  • 2020-12-17

Metadata

Anon_0  
expand all